Insiders · OCGN

Ramesh Kumar

Director at Ocugen, Inc. (OCGN)

Ramesh Kumar has filed 10 insider reports with the SEC since April 2021, as director at Ocugen, Inc. (OCGN). Ramesh Kumar made no open-market purchases or sales in the last 12 months. The latest filing, on June 9, 2023, reports grant or award at Ocugen, Inc. (OCGN).

Filings
10
Companies
1
Bought on market
None
Sold on market
$228K

Companies where Ramesh Kumar is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Ocugen, Inc. logo
OCGN
Ocugen, Inc.
Director0$228K$0.7392Jun 9, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Ramesh Kumar with

Other insiders at the same companies

Questions about Ramesh Kumar

What is Ramesh Kumar's role at Ocugen, Inc.?
Ramesh Kumar reports to the SEC as director at Ocugen, Inc. (OCGN), according to the latest filing on June 9, 2023.
Has Ramesh Kumar bought or sold stock recently?
The most recent open-market sale was on October 6, 2022: sold 4,500 shares of Ocugen, Inc. (OCGN) for $8,235 at an average of $1.83.
How do I get alerts when Ramesh Kumar files?
Follow Ramesh Kumar on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Ramesh Kumar (SEC CIK 0001580074). Totals count each trade once, skipping amendments whose original is on file, from Apr 21, 2021 on. View on SEC EDGAR